Skip to main content
logo
Norris Medicines Limited (BOM:524414)
India flag India · Delayed Price · Currency is INR
15.50
-0.50 (-3.13%)
At close: Jul 28, 2026

Norris Medicines Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
81.3281.3258.256.3683.5994.38
Revenue Growth
39.72%39.72%3.28%-32.58%-11.44%-22.96%
Gross Profit
38.2738.2723.1229.3648.3637.13
Operating Income
2.192.19-7.58-7.52.95-7.2
Net Income
-2.81-2.81-12.37-11.87-17.49-32.63
Earnings Per Share
-0.28-0.28-1.24-1.19-1.75-3.26
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
0.220.220.40.380.20.19
Total Debt
215.35215.35215.8215.24214.04210.77
Net Cash (Debt)
-215.14-215.14-215.41-214.86-213.84-210.58
Net Cash Growth
------
Net Cash Per Share
-21.47-21.47-21.54-21.48-21.38-21.06

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
5.785.785.11.712-10.09
Capital Expenditures
-0.1-0.1-0.19-0.01-0.3-0.55
Free Cash Flow
5.685.684.911.6911.7-10.65
Free Cash Flow Growth
15.67%15.67%191.17%-85.58%--

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
47.07%47.07%39.72%52.10%57.86%39.34%
Operating Margin
2.70%2.70%-13.03%-13.31%3.54%-7.63%
Pretax Margin
-3.45%-3.45%-20.24%-19.48%-14.28%-23.14%
Profit Margin
-3.45%-3.45%-21.26%-21.06%-20.93%-34.58%
FCF Margin
6.98%6.98%8.44%2.99%13.99%-11.28%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJul '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
P/FCF Ratio
27.2923.5134.1780.658.94-
PS Ratio
1.911.642.882.411.253.70